Market

Regulatory fast track for drug that targets chemotherapy-related hearing loss

FDA

Fennec Pharmaceuticals
© Srdjanns74 - iStock.com

Fennec Pharmaceuticals Inc., a small biotech operating from Durham, North Carolina, USA recently announced that it has been granted fast-track designation by the US FDA for its signature drug Pedmark (a unique formulation of sodium thiosulfate), WRALTechWire reports.

Read more...

Delight Global receives approval from US FDA to market in the United States

Market

Madrid
tunart - istock.com

Korea-based start-up Delight Global recently received the green light from the US Food and Drug Administration (FDA) to market its hearing aids in the United States.

Read more...

Walgreens and Starkey launch Walgreens Hearing

Partnership

Walgreens Hearing

Walgreens and Starkey Hearing Technologies are collaborating on hearing health centers in Walgreens stores, and have launched the first two centers last month in Minneapolis.

Read more...

Former Starkey head Ruzicka found guilty on multiple counts

Justice

Jerry Ruzicka
© G.B.

The $20m Starkey embezzlement trial ends with a split verdict and convictions for Starkey's former President Jerry Ruzicka.

Read more...

Amplifon in 2017: another record year for the group

Financial

© DR

The company has posted consistently favorable results and thanks to the record figures, Amplifon plans to propose a dividend to its shareholders that is 57% higher compared to 2016.

Read more...

Starkey Hearing cuts all ties with NRA

Manufacturers

© mecaleha - iStock.com

Starkey recently announced it would not renew its discount program with the National Rifle Association.

Read more...

Oticon Inc. appoints new Executive, Marketing and Sales Directors

Management

Oticon Opn
Dawn Spring (l.) and Josephine Poelma (r.) © Oticon

Oticon Inc. has announced the appointment of two Executive Directors and six Directors in marketing and sales.

Read more...

Priorities for future research in hyperacusis

Hyperacusis

© bowie15 - iStock.com

Researchers working at Nottingham Biomedical Research Centre and the University of Nottingham, UK recently examined the most important research questions in hyperacusis.

Read more...

Oricula Therapeutics: investigational new drug approved

Biotech

© scanrail - iStock.com

Oricula Therapeutics recently announced United States FDA approval for volunteer human studies of the safety, tolerability, and pharmacokinetics of a novel medicine, ORC-13661 in hearing protection.

Read more...

Spain hearing aid sales rally in 2017

Figures

Madrid
J.L.F.

The annual report from the GEA (Audiological Business Group)—issued now for the last three years—shows growth in the number of hearing aids sold in Spain for the financial year, 2017, a notable climb up of 3.7% (one percentage point more) on 2016.

Read more...